Sinocare Inc.

Shenzhen Stock Exchange 300298.SZ

Sinocare Inc. Total Assets for the year ending December 31, 2023: USD 834.81 M

Sinocare Inc. Total Assets is USD 834.81 M for the year ending December 31, 2023, a 24.77% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

Sinocare Inc. Total Assets for the year ending December 31, 2022 was USD 669.07 M, a 2.35% change year over year.
Sinocare Inc. Total Assets for the year ending December 31, 2021 was USD 653.68 M, a 9.52% change year over year.
Sinocare Inc. Total Assets for the year ending December 31, 2020 was USD 596.86 M, a 26.66% change year over year.
Sinocare Inc. Total Assets for the year ending December 31, 2019 was USD 471.22 M, a 8.03% change year over year.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

Shenzhen Stock Exchange: 300298.SZ

Sinocare Inc.

CEO	Mr. Shao Bo Li
IPO Date	March 19, 2012
Location	China
Headquarters	No. 265 Guyuan Road
Employees	4,531
Sector	Health Care
Industries Pharmaceuticals Hospitals & Clinics Medical Instruments

Description

Sinocare Inc. engages in the development, manufacture, and marketing of diagnosis rapid testing products primarily in the People's Republic of China. It offers SARS-CoV-2 antibody test strip; Safe-Accu blood glucose monitoring systems; Safe-AQ blood glucose monitoring systems; Gold-Accu blood glucose monitoring systems; Safe-Accu UG blood, glucose, and uric acid monitoring systems; Safe-Accu KG blood, glucose, and ketone monitoring systems; and D Nurse mobile glucose meters. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products to 135 countries. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.

Key trends

Past 5 years